AU6893281A - 4,6-disubstituted tetrahydropyran-2-one derivatives - Google Patents

4,6-disubstituted tetrahydropyran-2-one derivatives

Info

Publication number
AU6893281A
AU6893281A AU68932/81A AU6893281A AU6893281A AU 6893281 A AU6893281 A AU 6893281A AU 68932/81 A AU68932/81 A AU 68932/81A AU 6893281 A AU6893281 A AU 6893281A AU 6893281 A AU6893281 A AU 6893281A
Authority
AU
Australia
Prior art keywords
derivatives
disubstituted tetrahydropyran
tetrahydropyran
disubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68932/81A
Inventor
Aiya Sato
Akira Terahara
Yoshio Tsujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12604367&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU6893281(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU6893281A publication Critical patent/AU6893281A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
AU68932/81A 1980-03-31 1981-03-31 4,6-disubstituted tetrahydropyran-2-one derivatives Abandoned AU6893281A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55041292A JPH0692381B2 (en) 1980-03-31 1980-03-31 MB-530A derivative
JP4129280 1980-03-31

Publications (1)

Publication Number Publication Date
AU6893281A true AU6893281A (en) 1981-10-08

Family

ID=12604367

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68932/81A Abandoned AU6893281A (en) 1980-03-31 1981-03-31 4,6-disubstituted tetrahydropyran-2-one derivatives

Country Status (15)

Country Link
JP (1) JPH0692381B2 (en)
AT (1) ATA150781A (en)
AU (1) AU6893281A (en)
BE (1) BE888214A (en)
CH (1) CH646966A5 (en)
DE (2) DE3112566A1 (en)
DK (3) DK151273C (en)
FI (1) FI810991L (en)
FR (1) FR2479222A1 (en)
GB (1) GB2073193A (en)
IE (1) IE52367B1 (en)
IT (1) IT1144325B (en)
MX (1) MX9203567A (en)
NL (1) NL8101592A (en)
SE (1) SE461590B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472426A (en) * 1982-12-22 1984-09-18 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3682557D1 (en) * 1985-09-13 1992-01-02 Sankyo Co HYDROXY-ML-236B DERIVATIVES, THEIR PRODUCTION AND USE.
US4997848A (en) * 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US5075327A (en) * 1988-08-10 1991-12-24 Hoffmann-La Roche Inc. Antipsoriatic agents
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
US5021451A (en) * 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
US5159104A (en) * 1991-05-01 1992-10-27 Merck & Co., Inc. Process to simvastatin ester
FR2937537A1 (en) 2008-10-29 2010-04-30 Centre Nat Rech Scient NANOPARTICLES OF STATIN
KR101820099B1 (en) 2013-01-18 2018-01-18 에스프린팅솔루션 주식회사 resistive heat generating material, heating member and fusing device adopting the same
US11970482B2 (en) 2018-01-09 2024-04-30 Ligand Pharmaceuticals Inc. Acetal compounds and therapeutic uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (en) * 1974-06-07 1981-03-18
JPS5925599B2 (en) * 1979-02-20 1984-06-19 三共株式会社 New physiologically active substance monacolin K and its production method
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
US4282155A (en) * 1980-02-04 1981-08-04 Merck & Co., Inc. Antihypercholesterolemic compounds
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
ZA81703B (en) * 1980-02-04 1982-09-29 Merck & Co Inc New antihypercholesterolemic compounds,intermediates and processes

Also Published As

Publication number Publication date
DK167805B1 (en) 1993-12-20
DK32290A (en) 1990-02-07
DK32190A (en) 1990-02-07
CH646966A5 (en) 1984-12-28
SE8102047L (en) 1981-10-01
MX9203567A (en) 1992-09-01
DK145481A (en) 1981-10-01
BE888214A (en) 1981-09-30
DE3112566C2 (en) 1990-04-05
DK151273B (en) 1987-11-16
IT8167438A0 (en) 1981-03-30
JPS56138181A (en) 1981-10-28
DK151273C (en) 1988-07-04
DK32290D0 (en) 1990-02-07
GB2073193A (en) 1981-10-14
IE52367B1 (en) 1987-09-30
IT1144325B (en) 1986-10-29
FI810991L (en) 1981-10-01
FR2479222B1 (en) 1983-08-26
DE3112566A1 (en) 1982-03-11
JPH0692381B2 (en) 1994-11-16
DK32190D0 (en) 1990-02-07
NL8101592A (en) 1981-10-16
SE461590B (en) 1990-03-05
ATA150781A (en) 1983-03-15
DE3153666C2 (en) 1993-11-11
IE810698L (en) 1981-09-30
FR2479222A1 (en) 1981-10-02

Similar Documents

Publication Publication Date Title
AU544294B2 (en) 25-hydroxy-26,26,27,27,27,-hexa fluorocholecalciferol
AU7338081A (en) 1,2,4-triazolylpropenol derivatives
AU6893281A (en) 4,6-disubstituted tetrahydropyran-2-one derivatives
AU563950B2 (en) 2,2 -disubstituted-1,3-oxepine derivatives
AU544637B2 (en) 4,1-benzoxazepines
AU544357B2 (en) Substituted 1,2,4-triazole derivatives
AU547929B2 (en) 3,3-dimethylindolin-2-ones
AU1575383A (en) 1,4-dihyropyridine derivatives
AU541703B2 (en) 1,1-diacetoxyethane
AU547334B2 (en) 2,4-diaminopyrimidine derivatives
AU6881081A (en) Substituted-2,4,5-triarylthiazole derivatives
AU546548B2 (en) 1,2,4-triazolylethylenes
AU8413382A (en) 1,4-piperizine derivatives
AU7474881A (en) 1,2,4-triazole derivatives
AU545324B2 (en) 1,2,4-oxadiazolo (2,3-c)-pyrimidine derivatives
AU536894B2 (en) 4,9 - dioxonaphto-triazoles
AU535051B2 (en) 9-oxo-1h,9h-benzopyrano(2,3-0)-v-triazole derivatives
AU548045B2 (en) 2,3-dihydropyrans
AU568295B2 (en) 1,2,4-triazol-i-yl-propionitrile derivatives
AU8879882A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU7744681A (en) 2,3-dihydro-4-pyrone derivatives
AU542710B2 (en) 16-amino-17-phenyl-18,19,20-trinor-prosta-glandin derivatives
AU7301081A (en) 2-iodoacetylimino-3-methyl-5-trifluoromethyl 1,4- thiadiazol-4-ine
AU8879782A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU8471582A (en) 1,2,3,4alpha,9beta-hexahydro-4alpha-piperizinylmethyl-4- dibenzofuran-one or-dibenzofuranol derivatives